|
Beifuji Spray 63000IU/bottle
|
|
|
|
Introduction:
|
The main component of Beifuji is the basic
fibroblast growth factor, which is a multi-functional growth factor
with a wide range of activity. It can increase the proliferation of
mesoderm and neuroectoderm-drived cells such as epithelial cell,
dermal cell, fibroblast and vascular endothelial cell, etc.
The studies have shown that bFGF can promote new micro-vessel
formation, so as to improve the microcirculation in the bed of
wound, accelerate wound repair and healing and improve the quality
of wound healing. Therefore, it is a safe and efficient new medicine
for the treatment of wound.
Beifuji is also the sole one at home and the first in the world for
the wound healing with bFGF that is formally permitted to getting on
the market.
|
|
¡¡ |
Features:
¡ñ a
new
drug approved category I biopharmaceutical
product developed under genetic engineering in
the PRC,
¡ñ Accelerating the
healing of the wound and
shortening the time of healing of the wound surface,
¡ñ Decreasing
and avoiding the formation of scars,
¡ñ Increasing
the tearing resistance of the wound surface,
¡ñ Aseptic
package, diversified types and convenient for use,
¡ñ Highly
safe and non-toxic side effect.
¡¡ |
|
Indications:
¡ñ Various
acute and chronic ulcers, including diabetic ulcer, radioactive ulcer, deductible ulcer,
and
fistula, etc.
¡ñ Fresh
wounds, including trauma, cut, cold injury
and wound caused by laser, skin grafting
donor or
surgical
operation, etc.
¡ñ Burns
and scalds, including superficial
second degree burns,deep-second degree burns and
the granulation.
|
|
| |
|
|
|
¡¡ |
|
 |
